June 26 (Reuters) - Oryzon Genomics SA ORY.MC :
* INFORMS ON CAPITAL INCREASE BY CONVERSION OF CONVERTIBLE
BONDS
* NICE & GREEN APPLIES FOR CONVERSION OF BONDS FOR AGGREGATE
NOMINAL AMOUNT OF 480,000 EUROS
* CONVERSION PRICE OF EUR 1.8794 PER SHARE
* INCREASED ITS SHARE CAPITAL BY TOTAL NOMINAL AMOUNT OF
12,770
EUROS BY ISSUING AND PUTTING INTO CIRCULATION 255,400 NEW
ORDINARY SHARES WITH PAR VALUE OF 0.05 EUROS EACH
* NEW SHARES IN CO WILL BE ISSUED AT ISSUE PRICE OF EUR
1.8794 PER
SHARE (EUR 0.05 PAR VALUE PLUS EUR 1.8294 SHARE PREMIUM)
* TOTAL SHARE PREMIUM OF 467,228.76 EUR AND EFFECTIVE AMOUNT
OF
CAPITAL INCREASE OF 479,998.76 EUR
* FOLLOWING CAPITAL INCREASE, SHARE CAPITAL OF COMPANY HAS
BEEN
SET AT 3.1 MILLION EUROS
Source text for Eikon: ID:nCNM4FS5zb ID:nFWN3IG01A
Further company coverage: ORY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))